Skip to content

A Comparison of Capsules and Oral Spray Solution as Methods of Delivering Vitamin D3 and Raising Status

A Comparison of Capsules and Oral Spray Solution as Methods of Delivering Vitamin D3 and Raising Status: a Randomised Crossover Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02608164
Acronym
SCD3
Enrollment
22
Registered
2015-11-18
Start date
2015-08-31
Completion date
2016-05-31
Last updated
2016-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitamin D Concentration, Vitamin D Status

Keywords

Healthy adults

Brief summary

The aim of the study is to compare the effectiveness of a vitamin D3 oral spray solution with capsules at raising vitamin D status over winter. This randomised crossover trial will aim to recruit a total of 22 healthy participants for a total of two 4-week interventions separated by a 10-week washout.

Interventions

DIETARY_SUPPLEMENT3000IU(75μg) vitamin D3

Sponsors

Northern Ireland Executive
CollaboratorUNKNOWN
HSC Public Health Agency
CollaboratorUNKNOWN
University of Ulster
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Apparently healthy * Over the age of 18

Exclusion criteria

* Those that intend to consume a supplement containing vitamin D at any point during the study * Those under the age of 18. * Individuals that are on prescribed medication that is known to affect vitamin D metabolism * Those following a vegan diet * Sun-bed users * Participants that are planning a sun holiday during the study

Design outcomes

Primary

MeasureTime frameDescription
Total 25-hydroxyvitamin D concentrationAt baseline and weeks 4, 14 and 18Total 25-hydroxyvitamin D concentration will be determined using liquid chromatography-tandem mass spectrometry in collected serum samples

Secondary

MeasureTime frameDescription
Biomarkers of vitamin D metabolismAt baseline and weeks 4, 14 and 18Biomarkers of vitamin D metabolism, including parathyroid hormone and adjusted calcium will be quantified in collected serum samples by ELISA and using a clinical chemistry analyser
Dietary vitamin D intakeAt week 18 onlyDietary vitamin D and calcium intake will be estimated using a validated food frequency questionnaire

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026